Nov 24th, 2025

Novo's Ozempic Pill Fails in Alzheimer's Effort

Novo Nordisk shares PLUNGE after announcing that a pill version of Ozempic failed to slow the progression of Alzheimer's disease in two late-stage studies. Bloomberg's Madison Muller discusses the story on "Bloomberg Markets" with Scarlet Fu.